{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:19:05Z","timestamp":1780582745113,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jiac.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T16:24:55Z","timestamp":1409415895000},"page":"762-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae"],"prefix":"10.1016","volume":"20","author":[{"given":"Tumay","family":"Ipekci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Seyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orcun","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2014.08.007_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum beta-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2014.08.007_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.007_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijid.2010.02.2264","article-title":"Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines","volume":"14","author":"Bours","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.007_bib4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ijid.2013.04.005","article-title":"Evaluation of the in\u00a0vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey","volume":"17","author":"Demir","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.007_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","article-title":"Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009\u20132011","volume":"35","author":"Bouchillon","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.jiac.2014.08.007_bib6","series-title":"Performance standards for antimicrobial susceptibility testing;19th informational supplement","author":"Wayne","year":"2009"},{"key":"10.1016\/j.jiac.2014.08.007_bib7","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2014.08.007_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/2141-9248.126611","article-title":"Hospital and community isolates of uropathogens and their antibiotic sensitivity pattern from a tertiary care hospital in North West India","volume":"4","author":"Singhal","year":"2014","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.jiac.2014.08.007_bib9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"168","author":"Rodriguez-Bano","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2014.08.007_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jmii.2010.08.012","article-title":"Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan","volume":"44","author":"Liu","year":"2011","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.jiac.2014.08.007_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijantimicag.2012.08.003","article-title":"Nitrofurantoin in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infection","volume":"40","author":"Tasbakan","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2014.08.007_bib12","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/jac\/dkq346","article-title":"Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli","volume":"65","author":"Oteo","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-0711-8-27","article-title":"Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study","volume":"8","author":"Aypak","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jiac.2014.08.007_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1469-0691.2007.01852.x","article-title":"Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline","volume":"14","author":"Garau","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2014.08.007_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-0711-6-4","article-title":"Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India","volume":"6","author":"Akram","year":"2007","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jiac.2014.08.007_bib16","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1128\/AAC.00359-13","article-title":"Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa","volume":"57","author":"Tansarli","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib17","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1128\/AAC.00065-13","article-title":"Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010\u20132011","volume":"57","author":"Lee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib18","first-page":"115","article-title":"Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics","volume":"41","author":"Aykut","year":"2007","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jiac.2014.08.007_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.007_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/dkt404","article-title":"Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections","volume":"69","author":"Jansaker","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/mdr.2011.0161","article-title":"Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"18","author":"Titelman","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jiac.2014.08.007_bib22","first-page":"355","article-title":"Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection","volume":"22","author":"Senol","year":"2010","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3947\/ic.2013.45.4.415","article-title":"Outcome of antimicrobial therapy of pediatric urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0929-693X(12)71283-6","article-title":"Therapeutics strategies for the management of urinary tract infection in children","volume":"19","author":"Launay","year":"2012","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jiac.2014.08.007_bib25","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.35.9.1849","article-title":"Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study","volume":"35","author":"Fang","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib26","series-title":"Principles and practice of infectious diseases","first-page":"359","article-title":"Aminoglycosdes","author":"Gilbert","year":"2010"},{"key":"10.1016\/j.jiac.2014.08.007_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","article-title":"Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases","volume":"57","author":"Calbo","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.08.007_bib28","first-page":"777","article-title":"Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase","volume":"53","author":"Hori","year":"2007","journal-title":"Hinyokika Kiyo"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14002906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14002906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:52:20Z","timestamp":1761159140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X14002906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1341321X14002906"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.08.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}